Abstract:Interleukin-6 (IL-6), a pleriotropic cytokine, is proposed to play a crucial role in inflammatory response (ref). Further study shows that IL-6 also plays important roles during angiogenesis and vascular remodelling, depending upon cell types. We investigated the effects of IL-6 on a major cell type crucial for remodelling, human cerebral vascular smooth muscle cells (HCSMCs). HCSMCs were grown to confluence on gelatin coated 35 mm dishes and then treated with IL-6 protein at different concentrations (25–200 ng/ml). HCSMC proliferation was determined using a BrdU assay kit, and migration was determined using a HCSMC invasion assay. Expression of vascular endothelial growth factor (VEGF) and VEGF receptor, the kinase insert domain–containing receptor (KDR), and matrix metalloproteinase (MMP)-3, -9 protein and mRNA levels were determined using Western blot analysis, ELISA, and real time –polymerase chain reaction (RT-PCR) assay, respectively. MMP-9 activity was determined using MMP zymography. VEGF had a minimal mitogenic effect on HCSMCs. However, IL-6 induced HCSMC proliferation and migration in a dose dependent manner. To explore the signal transduction pathway for the effect of IL-6 on HCSMC proliferation, we studied the downstream factor expression in HCSMCs (VEGF, MMP-3, -9). IL-6 significantly enhanced VEGF, MMP-3, -9 both mRNA and protein expression levels in HCSMCs compared with the control (without IL-6 treatment, p<0.05), respectively. Neutralizing or inhibiting IL-6 and/or VEGF using antibodies or inhibitors could block IL-6 induced HCSMC proliferation. Importantly, we demonstrated that IL-6 directly activated KDR phosphorylation in the IL-6 treated HCSMCs. Blocking KDR abolished IL-6 induced HCSMC proliferation. Our results indicate that the IL-6 treatment accelerated HCSMC proliferation through stimulation of the VEGF-KDR-MMP signal pathway. We provide the first evidence that IL-6, by triggering KDR phosphorylation, plays an important role in IL-6 induced HCSMC proliferation. HCSMC-derived MMPs could be an additional source of proteases to digest vascular basement membranes, potentially providing a key step in the initial stage of brain angiogenesis. MMPs may also contribute to HCSMC migration in angiogenesis. Supported by NIH grants: PO1 NS and RO1 NS27713 (WLY) and R21 NS45123 (GYY)

IL-6 promotion of glioblastoma cell invasion and angiogenesis in U251 and T98G cell lines

Il-6 Augments The Invasiveness Of U87mg Human Glioblastoma Multiforme Cells Via Up-Regulation Of Mmp-2 And Fascin-1

Human Astrocytes Secrete Il-6 to Promote Glioma Migration and Invasion Through Upregulation of Cytomembrane Mmp14

Targeting Interleukin 6 Signaling Suppresses Glioma Stem Cell Survival and Tumor Growth.

Autocrine IL-8 Promotes F-actin Polymerization and Mediate Mesenchymal Transition Via ELMO1-NF-κB-Snail Signaling in Glioma

Interleukin-6 promotes pancreatic cancer cell migration by rapidly activating the small GTPase CDC42

Effects of IL-6 on Invasion of Pancreatic Cancer Cells and Its Mechanism

Interleukin 6 and cancer resistance in glioblastoma multiforme

Cnsc-66. Structural And Electrophysiological Connectivity In Glioblastoma Is Mediated By Tumor And Immune Derived Cytokines

Interleukin-11/IL-11 Receptor Promotes Glioblastoma Cell Proliferation, Epithelial–Mesenchymal Transition, and Invasion

TAMI-45. MICROGLIAL CYTOKINES INDUCE INVASIVENESS AND PROLIFERATION THROUGH PYK2 AND FAK ACTIVATION IN HUMAN GLIOBLASTOMA CELL

IL-13 Receptor Α2 Stimulates Human Glioma Cell Growth and Metastasis Through the Src/PI3K/Akt/mTOR Signaling Pathway.

Interleukin-6 triggers human cerebral smooth muscle cell proliferation

Interleukin-6 Induces an Epithelial-Mesenchymal Transition Phenotype in Human Adamantinomatous Craniopharyngioma Cells and Promotes Tumor Cell Migration

CXCL5 promotes the proliferation and migration of glioma cells in autocrine- and paracrine-dependent manners.

PPFIBP1 induces glioma cell migration and invasion through FAK/Src/JNK signaling pathway

Endothelial Cell-Derived Plasmin Promotes Human Glioma Cell Proliferation

Upregulation of microRNA‐133a and downregulation of connective tissue growth factor suppress cell proliferation, migration, and invasion in human glioma through the JAK/STAT signaling pathway

Interleukin-6 induces malignant transformation of rat mesenchymal stem cells in association with enhanced signaling of signal transducer and activator of transcription 3.

Glioblastoma-Derived IL6 Induces Immunosuppressive Peripheral Myeloid Cell PD-L1 and Promotes Tumor Growth

IL-6 cooperates with G-CSF to induce protumor function of neutrophils in bone marrow by enhancing STAT3 activation